DH Net Income Growth
44.81%TTM
Period ending:
DH TTM Net Income YoY %%
436.92%-3188.39%
2021-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
DH net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 19 observations from Dec 31, 2021 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| 44.8085% | |
| 66.6575% | |
| 66.3704% | |
| 48.2017% | |
| 24.7367% | |
| -155.6177% | |
| -104.1248% | |
| -99.8365% | |
| -2,837.5508% | |
| -1,766.9936% | |
| -2,702.3816% | |
| -558.7049% | |
| 65.9217% | |
| 78.5924% | |
| 86.0869% | |
| 51.6045% | |
| 21.2323% | |
| -111.461% | |
| -101.0068% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All DH financial metrics · DH stock overview · How to interpret financial metrics
